Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2023
RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA from Anderlecht, company number BE0402184269, closed financial year 2023 with a result of € 5.3 million after tax. For that financial year RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA recorded revenue of € 117.1 million and equity of € 108.8 million. Compared with financial year 2022, the result moved from € 2.8 million to € 5.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2024.
€ 108.8 million
▲ 5% vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5.3 million
▲ 91% vs 2022
Profit after tax over the fiscal year.
€ 4.8 million
▲ € 4.1 million vs 2022
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2023. Retained profit grew to € 59.3 million.
People and assets in 2023
65.3
▲ 2.4 vs 2022
Average over the fiscal year, from the social balance sheet.
€ 6.5 million
▲ 5% vs 2022
€ 98,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 100,389
▲ 15% vs 2022
Book value of vehicles, furniture and equipment.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 27.4 million
▲ 6% vs 2022
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 91 days on average.
€ 3.6 million
▲ 1% vs 2022
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|
| Revenue | € 111,234,301 | € 117,115,414 | ▲ 5% |
| Profit after taxes | € 2,774,002 | € 5,295,460 | ▲ 91% |
| Equity | € 103,494,031 | € 108,789,491 | ▲ 5% |
| Total debts | € 29,528,286 | € 31,154,721 | ▲ 6% |
| Cash | € 760,591 | € 4,838,169 | ▲ € 4.1 million |
| Land & buildings | € 197,550 | € 62 | ▼ € 197,488 |
| Retained profit | € 53,958,193 | € 59,253,653 | ▲ 10% |
| Balance sheet total | € 133,022,317 | € 139,944,212 | ▲ 5% |
| Employees (FTE) | 62.9 | 65.3 | ▲ 2.4 |
By revenue, RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA ranks 7th of 19 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Anderlecht that publish figures (fiscal year 2023).
Key figures of RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA, fiscal years 2022 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
Ask about RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA?
What happened at RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Valérie Gillis stepped down as director. NBB
- New annual accounts for financial year 2023: profit of € 5.3 million (▲ 91% vs 2022). filed late Source: NBB ↗
- Russel Taylor stepped down as director. NBB
- Nicolas Vrinat stepped down as director. NBB
- Valérie Gillis became a director. NBB
- Nicolas Vrinat became a director. NBB
- Russel Taylor became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2.8 million profit in 2022 to € 5.3 million profit in 2023.
Paid € 3.2 million in corporate taxes since 2022.
Best year ever: 2023, with € 5.3 million profit.
Pays suppliers within 91 days on average.
Management
The shares are held by Reckitt Benckiser France SAS (100%) and R&cC Nominees Limited (0%).
Directors
According to the 2023 annual accounts
Russel Taylor
Director
since 2021 · until 2024
Valérie Gillis
Administrator-manager
since 2023 · until 2027
Nicolas Vrinat
Managing director
since 2022 · until 2024
Shareholders
Reckitt Benckiser France SAS
100%
R&cC Nominees Limited
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Industrielaan 13B
1070 Anderlecht
Researchdreef 20
1070 Anderlecht
Active since 1 April 1921
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Anderlecht
Same main activity (Groothandel in farmaceutische en medische artikelen), 32 active companies in Anderlecht, largest first.
€ 4.6 billion revenue · 2025
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE
€ 580.7 million revenue · 2025
€ 472.7 million revenue · 2025
€ 448.8 million revenue · 2025
€ 152.2 million revenue · 2025
€ 131.2 million revenue · 2025
Details
- Company number
- 0402.184.269
- VAT number
- BE 0402.184.269
- Registered office
- Industrielaan 13B, 1070 Anderlecht
- Names & denominations
- RECKITT BENCKISER (BELGIUM)SA/NV ou RECKITT BENCKISER HEALTHCARE (BELGIUM) NV/SA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 April 1921
- Peppol
- Not registered
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Groothandel in reinigingsmiddelen
Vervaardiging van andere voedingsmiddelen, neg
Vervaardiging van overige voedingsmiddelen, n.e.g.